Use of cefoperazone MacConkey agar for selective isolation of Laribacter hongkongensisLAU, Susanna K. P; WOO, Patrick C. Y; HUI, Wai-Ting et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 10, pp 4839-4841, issn 0095-1137, 3 p.Article

Hypoprothrombinemia due to cefoperazoneMEISEL, S.Drug intelligence & clinical pharmacy. 1984, Vol 18, Num 4, issn 0012-6578, 316Article

Placental transfer of cefoperazone and sulbactam in the isolated in vitro perfused human placentaFORTUNATO, S. J; BAWDON, R. E; BAUM, M et al.American journal of obstetrics and gynecology. 1988, Vol 159, Num 4, pp 1002-1006, issn 0002-9378Article

Update on cephalosporin resistance and the role of sulbactam/cefoperazone. Satellite symposiumClinical infectious diseases. 1997, Vol 24, Num 3, pp 486-505, issn 1058-4838Conference Proceedings

Sulbactam-containing β-lactamase inhibitor combinationsAKOVA, M.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 185-188, issn 1470-9465, 4 p.Conference Paper

Une observation d'hypoprothrombinémie induite par le céfopérazone (Céfobis^®) = A case of cefoperazone induced hypoprothrombinemiaMORRIER, P; DABADIE, H; VETELET, P et al.Gastroentérologie clinique et biologique. 1985, Vol 9, Num 1, pp 87-88, issn 0399-8320Article

Voltammetric studies on the antibiotic drug cefoperazone Quantification and pharmacokinetic studiesHAMMAM, E; EL-ATTAR, M. A; BELTAGI, A. M et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 42, Num 4, pp 523-527, issn 0731-7085, 5 p.Article

Antimicrobial activity and other in vitro properties of cefoperazone A, the principal metabolite of cefoperazone sodiumJONES, R. N; BARRY, A. L.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 2, pp 293-296, issn 0066-4804Article

A unique case of bullous drug eruption related to vancomycin and cefoperazoneLI, Qianxi; CHEN, Jianyou; LI, Ruoyu et al.EJD. European journal of dermatology. 2014, Vol 24, Num 3, pp 378-379, issn 1167-1122, 2 p.Article

Alteration of hemostasis associated with cefoperazone treatmentANDRASSY, K; KODERISCH, J; FRITZ, S et al.Infection. 1986, Vol 14, Num 1, pp 27-31, issn 0300-8126Article

EMPIRIC THERAPY FOR BACTERIAL INFECTIONS: EVALUATION OF CEFOPERAZONE. A SYMPOSIUM HELD IN GENEVA, SWITZERLAND, OCTOBER 4-5, 1981KLEIN JO ED; NEU HC ED.1983; REVIEWS OF INFECTIOUS DISEASES; ISSN 0162-0886; USA; DA. 1983; VOL. 5; SUPPL. 1; 209 P.; BIBL. DISSEM.Conference Paper

Cefoperazone Induced Gastro-intestinal Haemorrhage. A Case ReportOZEN, I. O; MORALIOGLU, S; KARABULUT, R et al.Acta chirurgica belgica (Ed. bilingue). 2008, Num 6, pp 777-778, issn 0001-5458, 2 p.Article

The effect of control on the pattern of utilization of cefotaxime, moxalactam and cefoperazone in a teaching hospitalMA, M. Y; RHO, J. P.Drugs under experimental and clinical research. 1985, Vol 11, Num 2, pp 89-94, issn 0378-6501Article

Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazoneOZYUNCU, Ozgur; NEMUTLU, Emirhan; KATLAN, Doruk et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 2, pp 175-178, issn 0924-8579, 4 p.Article

Etude multicentrique hospitalière dune nouvelle céphalosporine de 3e génération: la céfopérazone, céfobis = Multicentric hospital study of a new cephalosporin of third generation: cefoperazone, cefobisBERTOYE.Gazette médicale de France (1969). 1984, Vol 91, Num 34, pp 131-133, issn 0016-5557Article

INTERACTION BETWEEN CEPHALOSPORINS AND ALCOHOLPORPACZY P.1981; INFECTION; ISSN 0300-8126; DEU; DA. 1981; VOL. 9; NO 4; PP. 210; BIBL. 3 REF.Article

Development of bacterial resistance to the third generation cephalosporins and their clinical useKOLAR, M; LATAL, T; HAJEK, V et al.Journal of chemotherapy. 1999, Vol 11, Num 4, pp 260-265, issn 1120-009XArticle

Cefoperazone: blood and CSF levels in patients with inflamed and uninflamed haematoencéphalic barrierCOSTANZO, E; FALSAPERLA, A; PENNISI, G et al.Drugs under experimental and clinical research. 1984, Vol 10, Num 1, pp 39-41, issn 0378-6501Article

Cefoperazone prevents the inactivation of α₁-antitrypsin by activated neutrophilsDALLEGRI, F; DAPINO, P; ARDUINO, N et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 9, pp 2307-2310, issn 0066-4804Article

Signal enhancement using a swellable polymer TSM acoustic wave sensor coatingCHANCE, J. J; PURDY, W. C.Analytical letters. 1999, Vol 32, Num 9, pp 1751-1760, issn 0003-2719Article

ESR spectroscopy applied to the study of pharmaceuticals radiosterilization : CefoperazoneBASLY, J. P; BASLY, I; BERNARD, M et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 17, Num 4-5, pp 871-875, issn 0731-7085Article

Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections : Results of a randomized, controlled clinical trialJIA-TAI, L; YUAN, L; LI-JIN, L et al.Clinical infectious diseases. 1997, Vol 24, Num 3, pp 498-505, issn 1058-4838Conference Paper

Solubility and Metastable Zone of Cefoperazone Sodium in Acetone + Water SystemQIAOLI CHEN; YONGLI WANG; YANBIN LI et al.Journal of chemical and engineering data (Print). 2009, Vol 54, Num 3, pp 1123-1125, issn 0021-9568, 3 p.Article

Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stoolsBYRNE, Catherine; DOHERTY, Deirdre; MOONEY, Adele et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 7, pp 2713-2716, issn 0095-1137Article

Comparison of the productivity of cefoperazone amphotericin teicoplanin (CAT) agar and modified charcoal cefoperazone deoxycholate (mCCD) agar for various strains of Campylobacter, Arcobacter and Helicobacter pullorumCORRY, J. E. L; ATABAY, H. I.International journal of food microbiology. 1997, Vol 38, Num 2-3, pp 201-209, issn 0168-1605Article